Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
guidance
Pharma
Teva forecasts $5B-plus in innovative drug sales by 2030
By 2030, Teva now expects to achieve at least $5 billion in innovative medicine sales, driven largely by Austedo, Ajovy and Uzedy.
Fraiser Kansteiner
May 30, 2025 7:20am
BMS accentuates the positive after Cobenfy trial flop
Apr 24, 2025 11:31am
J&J lifts 2025 sales guidance despite looming tariff threat
Apr 15, 2025 11:55am
WuXi AppTec offers rosy 2025 guidance despite US-China tensions
Mar 18, 2025 4:30pm
JPM25: Moderna slashes costs, guidance amid poor vaccine sales
Jan 13, 2025 11:31am
EuroAPI suspends 2024 guidance amid Italian production deficits
Mar 15, 2024 11:12am
